Best practice guidelines for melanoma care go digital
28 October 2016
Health professionals treating melanoma patients have access to the first in a series of new, wiki-based clinical recommendations with the launch of electronic clinical practice guidelines for the diagnosis and management of melanoma.
The release of the renewed resource, in Sydney at the Australasian Melanoma Conference, marks the first time a melanoma management guideline has been published in a wiki format for continual electronic update.
The first in a comprehensive series of updated melanoma guidelines, it provides evidence-based recommendations on the recognition of melanomas, biopsy of suspicious lesions, when to perform sentinel node biopsy and margins for radical excision of primary melanomas.
The guidelines are being developed in partnership by Cancer Council Australia and Melanoma Institute Australia, with additional funding from the Skin Cancer College Australasia.
Chair of the project’s expert working group, Professor John Thompson AO, said the guidelines were the result of an exhaustive systematic review and public consultation process and were being launched at a time of rapid change in the management of melanoma.
“Things are moving quickly in melanoma management,” Professor Thompson said. “A comprehensive systematic review of the evidence was timely.
“The publication of updated guidelines on Cancer Council Australia’s wiki platform means they can now be continually reviewed as new evidence becomes available. Using wiki software also means that we can publish guidelines in sections as they are finalised, rather than waiting for large paperbased volumes to be printed and distributed.”
One of the most significant changes in recommended practice in the new guideline was a strengthening of the evidence for sentinel node biopsy.
“The review found new evidence to support the use of sentinel node biopsy to accurately stage melanoma,” Professor Thompson said. “This is particularly important, given the advent of new effective but high-cost drugs that may be of value in appropriately staged patients.”
The guidelines will cover prevention, diagnosis, management and follow-up as well as special population groups such as children and pregnant women. The full set of guidelines is expected to be completed and published by early 2018.
The new set of guidelines are available online.
Read more on our Research Blog.
SAVE THE DATE:
Federal government urged
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Lauren O'Brien tells us why she's running for a cause close to her heart
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.
Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.
Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.
Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!
World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.
MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.